Skip to main content
Premium Trial:

Request an Annual Quote

Israel's Teva and Procognia to Collaborate on Biopharmaceuticals

NEW YORK (GenomeWeb News) – Teva Pharmaceutical Industries and the Israeli subsidiary of protein array company Procognia will collaborate on two biopharmaceutical products, the companies said today.
 
Under the agreement, Teva will have exclusive access to Procognia Israel’s glycoanalysis technology and related services.
 
Procognia will receive milestone and royalty payments from Teva, which will finance the collaboration.
 
Additional financial details were not disclosed.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.